Showing results (161-170 of 181) with videos related to
Sort By:
Pageof 19
Annals of Internal Medicine|September 27, 2021
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.BMJ (Clinical Research Ed.)|March 8, 2017
Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort studyRishi J Desai, Brian T Bateman, Krista F Huybrechts, et al.The Journal of Rheumatology|May 2, 2021
Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine LearningFredrik D Johansson, Jamie E Collins, Vincent Yau, et al.Arthritis Care & Research|January 15, 2021
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee ReplacementChandrasekar Gopalakrishnan, Rishi J Desai, Jessica M Franklin, et al.American Journal of Epidemiology|December 6, 2018
Multinomial Extension of Propensity Score Trimming Methods: A Simulation StudyKazuki Yoshida, Daniel H Solomon, Sebastien Haneuse, et al.The American Journal of Medicine|February 10, 2015
Use of osteoporosis medications after hospitalization for hip fracture: a cross-national studySeoyoung C Kim, Mi-Sook Kim, Gabriel Sanfélix-Gimeno, et al.BMC Rheumatology|March 20, 2019
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndromeSeoyoung C Kim, Marcelo F Di Carli, Rajesh K Garg, et al.BMC Endocrine Disorders|September 11, 2015
Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)Jennifer M Polinski, Seoyoung C Kim, Dingfeng Jiang, et al.Pharmacoepidemiology and Drug Safety|July 13, 2019
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilarsRishi J Desai, Seoyoung C Kim, Jeffrey R Curtis, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 11, 2020
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) studyRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.Pageof 19